Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Currently predicting for Mon, 13 May 2024

Trading levels for TCRT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.46 9.51 %
R2 1.41 6.07 %
R1 1.38 3.94 %
Current price: 1.33
Support S1 1.29 -2.94 %
S2 1.26 -5.07 %
S3 1.22 -8.52 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.59 19.55 %
R2 1.54 15.79 %
R1 1.40 5.26 %
Current price 1.33
Support S1 1.32 -0.752%
S2 1.30 -2.26%
S3 1.29 -3.01%

TCRT Predictions History

3 months ago
mterick54.410863 predicted that TCRT for Feb. 5th is going

Rank:

3 months ago
PredictionBot.Kathy predicted that TCRT for Jan. 22nd is going $0.127 (0.35%)

3 months ago
PredictionBot.Warren predicted that TCRT for Jan. 22nd is going $0.124 (-2.35%)

3 months ago
mterick54.410863 predicted that TCRT for Jan. 22nd is going

Rank:

1 year ago
starstx333 predicted that TCRT for 2022-09-27 is going

Rank:

1 year ago
JS predicted that TCRT for 2022-09-12 is going $3.75 (6.53%)

1 year ago
JS predicted that TCRT for 2022-08-26 is going $2.54 (-5.22%)

1 year ago
kyle.amilhiot.340399 predicted that TCRT for 2022-08-26 is going

Rank:
Click to get the best stock tips daily for free!

About Alaunos Therapeutics, Inc.

Alaunos Therapeutics. Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to... TCRT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT